These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7813560)

  • 1. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat.
    Castel MN; Morino P; Nylander I; Terenius L; Hökfelt T
    Eur J Pharmacol; 1994 Sep; 262(1-2):1-10. PubMed ID: 7813560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain.
    Castel MN; Morino P; Frey P; Terenius L; Hökfelt T
    Neuroscience; 1993 Aug; 55(3):833-47. PubMed ID: 8105419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
    Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
    Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE; Stoessl AJ
    Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus.
    Brog JS; Zahm DS
    Neuroscience; 1996 Oct; 74(3):805-12. PubMed ID: 8884776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the neurotensin striato-nigral pathway by D1 receptors.
    Castel MN; Morino P; Hökfelt T
    Neuroreport; 1993 Dec; 5(3):281-4. PubMed ID: 7507725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment.
    Castel MN; Morino P; Dagerlind A; Hökfelt T
    Eur J Neurosci; 1994 Apr; 6(4):646-56. PubMed ID: 7517773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression.
    Marshall JF; Henry BL; Billings LM; Hoover BR
    Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A; Zivkovic B; Bartholini G
    Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.
    Carta AR; Frau L; Pinna A; Morelli M
    Exp Neurol; 2010 Aug; 224(2):395-402. PubMed ID: 20452347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
    Letter AA; Merchant K; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
    Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
    Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.